Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Rhode Island Dept. Of Health Applauds New Tobacco Law, USA
The Rhode Island Department of Health (HEALTH) recognizes and applauds the significant public health achievement of The Family Smoking Prevention and Tobacco Control Act being signed into law. This new law gives the U.S. Food and Drug Administration (FDA) the authority to regulate tobacco products.

Secretary Sebelius Releases New Success Story Report: Community-Based Prevention Program In Nebraska Helps Prevent Heart Disease And Stroke
HHS Secretary Kathleen Sebelius today released the second in a series of health care success story reports that document innovative programs and initiatives that can serve as models for a reformed American health care system. Today"s report highlights the Nebraska WISEWOMAN program. WISEWOMAN is a community intervention program funded by the Centers for Disease Control and Prevention that helps prevent heart disease and stroke by providing screenings and counseling for low-income women. The report is available at http://www.healthreform.gov.
News of the day
Yaupon Therapeutics Completes Patient Enrollment For Pivotal Phase 2 Study Of Clearazide For Treatment Of Cutaneous T-cell Lymphoma
Yaupon Therapeutics, a privately held specialty pharmaceutical company, has announced it has completed enrollment for a pivotal Phase 2 clinical trial for Clearazide for the treatment of early-stage cutaneous T-cell lymphoma (CTCL - stages 1-2a). The study, which is being conducted under a Special Protocol Assessment (SPA) with the FDA, has enrolled 260 patients in 13 of the top cancer centers in the US. Yaupon expects the last patient to complete treatment in the study by June of 2010 and, assuming positive results, will file its NDA shortly thereafter.
Health Insurance

Ugandan Medical Male Circumcision Program Launched To Prevent HIV Transmission

Uganda was the first country in sub-Saharan Africa to register a drop in adult national prevalence in HIV. The epidemic, however, remains serious as approximately one million Ugandans are HIV positive. Experts in the field have begun promoting a low cost and powerful weapon against new HIV infections: voluntary medical male circumcision. Three trials in Kenya, Uganda and South Africa have demonstrated that male circumcision reduces the rate of HIV infection in heterosexual relationships by 50 to 60 percent. Male circumcision has received endorsements by the World Health Organization and the Uganda Ministry of Health as a proven safe way to prevent the spread of HIV. Yesterday, the Kayunga District Hospital and Makerere University Walter Reed Project (MUWRP) opened the Kayunga District Medical Male Circumcision Program, the first free, non-research male circumcision program in Uganda. They marked the grand opening on July 9th at a ribbon-cutting ceremony at a renovated clinic. Dr. Ahmed Matovu, Kayunga District Hospital Superintendent added, "Circumcision must be utilized in combination with Uganda"s existing HIV sexual prevention messages, which include condom use, faithfulness, or abstinence." "The Kayunga District Medical Male Circumcision Program, which has already circumcised more than 220 men, represents hope and progress in the fight against HIV," said MUWRP"s Mark Breda. Representatives from the Kayunga District Health Authority, Kayunga District Hospital, Uganda AIDS Control Program, Uganda AIDS Commission, and the U.S. government commemorated the day along with musical performances and a tree planting ceremony. The entire Kayunga community was invited. Participation included the males that have already been circumcised, ranging in age from 13-60, with the average age being 19. The program is funded using President"s Emergency Plan for AIDS Relief (PEPFAR) country operational funding. Kayunga is a rural district located in the mid-central part of Uganda, with an estimated population of 320,000 (Uganda population census 2002). The overall estimated prevalence of HIV infection in the district is 9.9%. MUWRP is a non-profit partnership with Makerere University and the U.S. Military HIV Research Program (MHRP). While its primary focus has been on developing a globally effective preventive HIV-1 vaccine, MHRP is actively committed to and engaged in providing effective prevention, care and treatment programs in the communities where they conduct research. U.S. Military HIV Research Program


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009